Advertisement

Picture Berlin Partner Top News CRIPSR Repairs Immune Cells 650x100px
Document › Details

Rentschler Biopharma SE. (10/4/17). "Press Release: Rentschler Biotechnologie GmbH Announces Transition into a European Corporation Called Rentschler Biopharma SE". Laupheim.

Organisations Organisation Rentschler Biopharma SE
  Group Rentschler (Group)
  Organisation 2 Rentschler Biotechnologie GmbH
  Today Rentschler Biopharma SE
  Group Rentschler (Group)
Products Product contract manufacturing (biologicals)
  Product 2 BIO-Europe 2017 Berlin
Persons Person Rentschler, Nikolaus F. (Rentschler Biotechnologie 201604– Supervisory Board before Managing Director (CEO))
  Person 2 Starnecker, Alexander (Rentschler 201710 Manager Company Development)
     


Rentschler Biotechnologie GmbH has successfully transitioned into a European corporation (SE) on October 1, 2017. The Company is operating as Rentschler Biopharma SE with immediate effect.


Rentschler Biotechnologie GmbH, a leading contract development and manufacturing organization (CDMO) for biopharmaceuticals, today announced that the Company has successfully transitioned into a European corporation (SE) with entry into the German commercial register on October 1, 2017. The Company is operating as Rentschler Biopharma SE with immediate effect. There will be no operational changes for clients or employees of the family-owned company due to the transition.

"With our transition to Rentschler Biopharma SE, we emphasize our long-term international corporate identity, while the core business remains unaffected. In future, this legal form of company strengthens our position as a full-service CDMO and ensures our place as a leader in this industry," commented Prof. Dr. Nikolaus F. Rentschler, Owner of Rentschler Biopharma SE. "Our proven service offering along the entire value chain - from bioprocess development through biomanufacturing to fill and finish of biopharmaceuticals - remains unchanged. This also applies to our company sites and manufacturing facilities as well as the existing client relations and importantly their contact persons."

Over the recent years, Rentschler Biopharma has grown considerably and invested constantly in facilities so that capacities have more than doubled. With the expansion of our facilities, a continually growing number of employees has also been added to the Company. About 200 employees have been recruited in all business segments during the past year and a half. In the current fiscal year, over 120 additional positions are to be filled.

Rentschler will present itself as Rentschler Biopharma SE for the first time at the 23rd Annual International Partnering Conference BIO-Europe at booth 42/43. The conference takes place November 6-8, 2017 at Messe Berlin.

The term "European Corporation", from the Latin: Societas Europaea (SE), is a legal form for incorporated companies in the European Union and the European Economic Area and enables the foundation of companies according to standardized legal principles.


About Rentschler Biopharma SE

Rentschler Biopharma SE, located in Laupheim, Germany, is a leading contract development and manufacturing organization (CDMO) for bioprocess development and manufacturing of biopharmaceuticals as well as for related consulting activities in terms of project management and regulatory support. The Company's clients include innovative biotech companies and major pharmaceutical companies around the world. Many years of experience and excellence in finding solutions as well as certified quality management and advanced technologies ensure Rentschler Biopharma's high quality standards. Rentschler Biopharma is a family-owned company employing approximately 750 people.

Contact Person:
Rentschler Biopharma SE
Dr. Alexander Starnecker
Manager Company Development
communications@rentschler-biopharma.com

   
Record changed: 2023-06-05

Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

More documents for Rentschler (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture EBD Group World of Partnering Opportunities 650x300px




» top